Skip to content

ADVANCED OXYGEN TECHNOLOGIES, INC.: 10-Q filed 2025-01-17

What ADVANCED OXYGEN TECHNOLOGIES, INC. reported in its quarterly report filed 2025-01-17 (fiscal Q2 2025): 30 published measures, 93 facts as tagged in accession 0001477932-25-000332.

This filing

Form
10-Q (quarterly report)
Filed
2025-01-17
Fiscal period
fiscal Q2 2025
Accession
0001477932-25-000332 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ADVANCED OXYGEN TECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-12-31629,013USD
At 2024-06-30675,214USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-12-31307,093USD
At 2024-06-30333,277USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-12-31321,920USD
At 2024-09-30368,206USD
At 2024-06-30341,937USD
At 2023-12-31360,497USD
At 2023-09-30324,342USD
At 2023-06-30350,779USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-10-01 to 2024-12-315,152USD92
2024-07-01 to 2024-12-31677USD184
2023-10-01 to 2023-12-313,434USD92
2023-07-01 to 2023-12-31328USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-07-01 to 2024-12-3115,369USD184
2023-07-01 to 2023-12-3122,177USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-10-01 to 2024-12-3113,256USD92
2024-07-01 to 2024-12-3124,141USD184
2023-10-01 to 2023-12-3110,501USD92
2023-07-01 to 2023-12-3121,134USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-07-01 to 2024-12-31-45,080USD184
2023-07-01 to 2023-12-31-20,408USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-12-31-20,756,094USD
At 2024-06-30-20,756,771USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-10-01 to 2024-12-313,292,945shares92
2024-07-01 to 2024-12-313,292,945shares184
2023-10-01 to 2023-12-313,292,945shares92
2023-07-01 to 2023-12-313,292,945shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-10-01 to 2024-12-313,302,945shares92
2024-07-01 to 2024-12-313,302,945shares184
2023-10-01 to 2023-12-313,302,945shares92
2023-07-01 to 2023-12-313,302,945shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-10-01 to 2024-12-310USD/shares92
2024-07-01 to 2024-12-310USD/shares184
2023-10-01 to 2023-12-310USD/shares92
2023-07-01 to 2023-12-310USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-10-01 to 2024-12-310USD/shares92
2024-07-01 to 2024-12-310USD/shares184
2023-10-01 to 2023-12-310USD/shares92
2023-07-01 to 2023-12-310USD/shares184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-10-01 to 2024-12-312,944USD92
2024-07-01 to 2024-12-315,245USD184
2023-10-01 to 2023-12-311,774USD92
2023-07-01 to 2023-12-314,031USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-12-31563,277USD
At 2024-06-30579,588USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-10-01 to 2024-12-317,744USD92
2024-07-01 to 2024-12-315,570USD184
2023-10-01 to 2023-12-314,835USD92
2023-07-01 to 2023-12-314,064USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-12-3165,736USD
At 2024-06-3095,626USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-12-31307,093USD
At 2024-06-30206,248USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-12-312,450USD
At 2024-06-301,050USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-10-01 to 2024-12-315,512USD92
2024-07-01 to 2024-12-3118,571USD184
2023-10-01 to 2023-12-315,666USD92
2023-07-01 to 2023-12-3117,070USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-12-313,292,945shares
At 2024-06-303,292,945shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-12-3164,563USD
At 2024-06-3094,482USD
At 2023-12-31108,015USD
At 2023-06-30104,836USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-12-3121,057,116USD
At 2024-06-3021,057,116USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2024-12-31-12,081USD
At 2024-06-308,613USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2024-12-31127,029USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-10-01 to 2024-12-318,096USD92
2024-07-01 to 2024-12-315,922USD184
2023-10-01 to 2023-12-315,208USD92
2023-07-01 to 2023-12-314,359USD184

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-10-01 to 2024-12-315,152USD92
2024-07-01 to 2024-12-31677USD184
2023-10-01 to 2023-12-313,434USD92
2023-07-01 to 2023-12-31328USD184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2024-10-01 to 2024-12-31-46,286USD92
2024-07-01 to 2024-12-31-20,017USD184
2023-10-01 to 2023-12-3136,155USD92
2023-07-01 to 2023-12-319,718USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-10-01 to 2024-12-311,512USD92
2024-07-01 to 2024-12-313,552USD184
2023-10-01 to 2023-12-311,666USD92
2023-07-01 to 2023-12-313,570USD184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-10-01 to 2024-12-31352USD92
2024-07-01 to 2024-12-31352USD184
2023-10-01 to 2023-12-31373USD92
2023-07-01 to 2023-12-31295USD184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-07-01 to 2024-12-310USD184
2023-07-01 to 2023-12-31285USD184

Inspect the source

Entity
ADVANCED OXYGEN TECHNOLOGIES, INC. / CIK 0000352991
Captured
2026-09-19T14:57:13.072Z
SEC response SHA-256
5153194a6f819ef350892f1fe4b2a3d742337aaf701081ccd5803d9ace356acb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000352991.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))